Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial is comparing injectable semaglutide to dulaglutide for people with type 2 diabetes and cardiovascular risk — given my specific heart health situation, would one of these medications already be considered a better fit for me outside of a trial?
2. 2The trial is listed as 'active, not recruiting,' which means they're no longer enrolling new participants — does that mean this study is no longer an option for me, and are there similar ongoing trials comparing these two medications that I could still join?
3. 3Since the main thing being measured is a combination of death from any cause, heart attack, or stroke, what does my current cardiovascular risk profile look like, and how might that affect whether a trial like this would be relevant to my situation?
4. 4Both semaglutide and dulaglutide are already approved medications — can you help me understand whether starting one of them now as a standard treatment might make more sense for me than waiting to find a comparable trial?
5. 5This trial has no listed phase, which can sometimes mean it's a large outcomes study rather than an early safety test — what should I understand about the level of evidence already available for these two drugs before deciding whether a trial like this is the right path for me?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.